ElSayed NA, et al. 7. Diabetes technology: standards of care in diabetes-2023. Diabetes Care. 2023;46(Suppl 1):S111–27.

Article  PubMed  Google Scholar 

American Diabetes, A. Standards of medical care in diabetes–2014. Diabetes Care. 2014;37(Suppl 1):S14-80.

Article  Google Scholar 

Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jiang T, et al. The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes. 2010;59(4):850–60.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137–88.

Article  CAS  PubMed  Google Scholar 

Mohan T, et al. Role of Nrf2 dysfunction in the pathogenesis of diabetic nephropathy: therapeutic prospect of epigallocatechin-3-gallate. Free Radic Biol Med. 2020;160:227–38.

Article  CAS  PubMed  Google Scholar 

Wang J, et al. NRF2-related epigenetic modifications in cardiac and vascular complications of diabetes mellitus. Front Endocrinol (Lausanne). 2021;12:598005.

Article  PubMed  Google Scholar 

Vodošek Hojs N, Bevc S, Ekart R, Hojs R. Oxidative stress markers in chronic kidney disease with emphasis on diabetic nephropathy. Antioxidants (Basel, Switzerland). 2020;9(10):925. https://doi.org/10.3390/antiox9100925.

Guo Y, et al. Epigenetic regulation of Keap1-Nrf2 signaling. Free Radic Biol Med. 2015;88(Pt B):337–49.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taheri Z, et al. Evaluation of the Epigenetic demethylation of NRF2, a master transcription factor for antioxidant enzymes, in colorectal cancer. Rep Biochem Mol Biol. 2020;9(1):33–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu M, et al. Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice. Kidney Int. 2009;76(3):277–85.

Article  CAS  PubMed  Google Scholar 

Silva-Llanes I, Shin CH, Jiménez-Villegas J, Gorospe M, Lastres-Becker I. The transcription factor NRF2 has epigenetic regulatory functions modulating HDACs, DNMTs, and miRNA biogenesis. Antioxidants (Basel, Switzerland). 2023;12(3):641. https://doi.org/10.3390/antiox12030641.

Pergola PE, et al. Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med. 2011;365(4):327–36.

Article  CAS  PubMed  Google Scholar 

Choi HK, et al. Inhibition of liver fibrosis by solubilized coenzyme Q10: role of Nrf2 activation in inhibiting transforming growth factor-beta1 expression. Toxicol Appl Pharmacol. 2009;240(3):377–84.

Article  CAS  PubMed  Google Scholar 

Bell KF, et al. Neuronal development is promoted by weakened intrinsic antioxidant defences due to epigenetic repression of Nrf2. Nat Commun. 2015;6:7066.

Article  CAS  PubMed  Google Scholar 

Zhao Y, et al. Oxidative stress-induced miR-27a targets the redox gene nuclear factor erythroid 2-related factor 2 in diabetic embryopathy. Am J Obstet Gynecol. 2018;218(1):136 e1-136 e10.

Article  PubMed  Google Scholar 

Seto E, Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol. 2014;6(4):a018713.

Article  PubMed  PubMed Central  Google Scholar 

Bannister AJ, Kouzarides T. Regulation of chromatin by histone modifications. Cell Res. 2011;21(3):381–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Itoh K, et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997;236(2):313–22.

Article  CAS  PubMed  Google Scholar 

Jeong Y, et al. Histone deacetylase isoforms regulate innate immune responses by deacetylating mitogen-activated protein kinase phosphatase-1. J Leukoc Biol. 2014;95(4):651–9.

Article  PubMed  Google Scholar 

Sathishkumar C, et al. Augmentation of histone deacetylase 3 (HDAC3) epigenetic signature at the interface of proinflammation and insulin resistance in patients with type 2 diabetes. Clin Epigenetics. 2016;8:125.

Article  PubMed  PubMed Central  Google Scholar 

Wang X, et al. Histone deacetylase 4 selectively contributes to podocyte injury in diabetic nephropathy. Kidney Int. 2014;86(4):712–25.

Article  CAS  PubMed  Google Scholar 

Hong Q, et al. Increased podocyte Sirtuin-1 function attenuates diabetic kidney injury. Kidney Int. 2018;93(6):1330–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi L, et al. MiR-339 is a potential biomarker of coronary heart disease to aggravate oxidative stress through Nrf2/FOXO3 targeting Sirt2. Ann Palliat Med. 2021;10(3):2596–609.

Article  PubMed  Google Scholar 

Zhao M, et al. Sirt2 in the spinal cord regulates chronic neuropathic pain through Nrf2-mediated oxidative stress pathway in rats. Front Pharmacol. 2021;12:646477.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong YA, Kim JE, Jo M, Ko GJ. The role of sirtuins in kidney diseases. Int J Mol Sci. 2020;21(18):6686. https://doi.org/10.3390/ijms21186686.

Zhu C, et al. Multiple roles of SIRT2 in regulating physiological and pathological signal transduction. Genet Res (Camb). 2022;2022:9282484.

Article  PubMed  Google Scholar 

Kim A, et al. NRF2-mediated SIRT3 induction protects hepatocytes from ER stress-induced liver injury. FASEB J. 2022;36(3):e22170.

Article  CAS  PubMed  Google Scholar 

Wang B, et al. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. Free Radic Biol Med. 2012;52(5):928–36.

Article  CAS  PubMed  Google Scholar 

Sonthalia M, et al. Histone deacetylase inhibitors as antidiabetic agents: advances and opportunities. Eur J Pharmacol. 2022;935:175328.

Article  CAS  PubMed  Google Scholar